Abstract
A chemiluminescent method is proposed for quantitation of NO generation in cell cultures. The method is based on activation of soluble guanylyl cyclase by NO. The product of the guanylyl cyclase reaction, pyrophosphate, is converted to ATP by ATP sulfurylase and ATP is detected in a luciferin–luciferase system. The method has been applied to the measurement of NO generated by activated murine macrophages (RAW 264.7) and bovine aortic endothelial cells. For macrophages activated by lipopolysaccharide and γ-interferon, the rate of NO production is about 100 amol/(cell·min). The rate was confirmed by the measurements of nitrite, the product of NO oxidation. For endothelial cells, the basal rate of NO generation is 5 amol/(cell·min); the rate approximately doubles upon activation by bradykinin, Ca2+ ionophore A23187 or mechanical stress. For both types of cells the measured rate of NO generation is strongly affected by inhibitors of NO synthase. The sensitivity of the method is about 50 pM/min, allowing the registration of NO generated by 102–104 cells. The enzyme-linked chemiluminescent method is two orders of magnitude more sensitive than fluorescent detection using 4-amino-5-methylamino-2′,7′-difluorofluorescein (DAF-FM).
Keywords: Nitric oxide, Guanylyl cyclase, Pyrophosphate, Macrophages, Endothelial cells, Thermostable luciferase
1. Introduction
Nitric oxide (NO) plays an important role as a signaling molecule in regulation of smooth muscle tone [1], neurotransmission [2] and immune response [3,4]. Due to this universal role, its generation is crucial for the symptoms and pathology of numerous diseases [5–10], including AIDS, sickle-cell disease, diabetes and pulmonary hypertension. Depending on its level, NO can either promote or inhibit tumor progression [11] and plays role in ischemia/reperfusion injury [12]. These facts illustrate the importance of a quantitative assay for nitric oxide in biological systems at physiologically and pathologically relevant levels.
Methods currently in use for biological systems including chemiluminescent reaction with ozone, electrochemical detection, fluorescent detection and EPR approaches are summarized in reviews [13,14]. Enzyme-linked NO detection suggested in our and other works [15–17] is based on the changing of catalytic activity of an enzyme in the presence of NO. The concept, first suggested in our publication [17], is outlined on Scheme 1. Here the target enzyme is the natural target of nitric oxide, soluble guanylyl cyclase (sGC), NO serves as a catalytic molecule rather than a direct analyte and detection is based on luciferin–luciferase chemiluminescence. This method was demonstrated in simple NO-generating systems, such as NO donors (NONOates) and inducible NO synthase (iNOS). The aim of the current study is to extend the method to quantification of NO generation in cell culture.
Scheme 1.

General outline of the chemiluminescence detection of nitric oxide. Soluble guanylyl cyclase converts GTP to cGMP and pyrophosphate (PPi) in reaction accelerated by NO. The product of the reaction, PPi, is converted to ATP by ATP-sulfurylase. Finally, ATP causes the light emission centered at 560 nm in luciferase reaction.
As it follows from the scheme, NO-activated soluble guanylyl cyclase (sGC) produces pyrophosphate (PPi), the latter being immediately converted to ATP by ATP-sulfurylase. Thus, at a constant NO concentration, ATP is constantly produced, generating linear increase in ATP-dependent luminescence. It means the slope of the luminescence vs. time curve provides the measure of the steady-state NO concentration in solution, reflecting the rate of NO generation.
In current work, enzymatic assay was applied to two cell types: murine macrophages (RAW 264.7 and primary murine bone marrow macrophages) and bovine aortic endothelial cells (BAEC). It should be noted that unlike methods employing fluorescent dyes that penetrate inside the cell, the assay detects extracellular NO. The level of available NO outside the producing cell is physiologically relevant when intracellularly produced nitric oxide is consumed by intracellularly produced superoxide, making less nitric oxide available for intercellular communication [18].
2. Materials and methods
2.1. Materials
2.1.1. Chemicals (catalog number in parentheses)
ATP (A7699), sodium pyrophosphate (S6422), DTPA (D6518), Dluciferin (L6152), adenosine-5′-phosphosulfate sodium salt (A5508, APS), Trizma base (T1503), DTT (43817), 2,3-diaminonaphthalene (D2757), E. coli lipopolysaccharide (L3129, LPS), bradykinin acetate (B3259), calcium ionophore A23187 (C7522), EGTA (E4378) were from Sigma–Aldrich. HEPES (H9897), arginine (BP370), GTP (R0461, 100 mM aqueous solution), Coomassie Plus (Bradford) Assay Kit (23236) were from Fisher Scientific. Magnesium chloride (194698) was from MP Biomedicals. NG-monomethyl- L-arginine (80200, NMMA), NG-nitro- L-arginine methyl ester (80210, NAME), DETA NONOate (82120), 7-nitroindazole (81340) were from Cayman Chemical. Murine interferon-γ (315-05) was from PeproTech.
2.1.2. Enzymes
Guanylyl cyclase (ALX-202-039) was from Alexis Biochemicals; ATP sulfurylase (M0394L) was from New England Biolabs; inorganic pyrophosphatase (I1891), firefly luciferase (L9506), superoxide dismutase (S9697), BSA (A7906) were from Sigma–Aldrich.
2.1.3. Engineered luciferases
Promega Ultra-Glo luciferase was prepared from luciferin detection reagent (CYP1A1 assay) as described in Supplement. The thermostable Green Luciferase (GR-TS) was expressed in E. coli (BL21(DE3)) as GST fusion protein and purified following the corresponding protocol [19].
2.1.4. NO donors
A stock solution of DETA NONOate was prepared in 0.01 M NaOH, and its concentration was determined using ε = 7640 M−1 cm−1 at 252 nm. The stock solution was diluted with water to necessary concentration prior to use.
2.1.5. Cells
Murine macrophages (RAW264.7) were grown in DMEM with 10% FBS and were stimulated with INF-γ (100 units/mL, 18 h) and then LPS (20 ng/mL, 4 h). The other details of cell maintenance are given in Supplement.
2.1.6. Buffers
MP-HEPES (for macrophages): 0.137 M NaCl, 2.7 mM KCl, 30 mM HEPES, 1 mM arginine, 2 mM glutamine, 20 mM glucose, pH 7.4 at 25 °C.
Hi HEPES (for endothelial cells): 0.18 M HEPES (titrated by NaOH), 5.4 mM KCl, 1 mM MgCl2, 10 mM glucose, 2 mM glutamine, 1 mM arginine, pH 7.55 at 25 °C. Where indicated, this buffer contained 1.3 mM CaCl2.
2.2. Instrumentation
Luminescence and fluorescence measurements were conducted at 37 °C using plate reader Victor3 (Perkin–Elmer), with black or white clear bottom 96-well plates (Nunclon, 137101 and 165306). Nitrite assays were run on spectrofluorometer (Hitachi), excitation 365 nm, emission 404 nm, bandwidth 2 nm.
2.3. Methods
2.3.1. Composition of the reaction mixture for NO measurements
Unless otherwise stated, the reaction mixture for luminescence measurements (200 μL) contained: 1 mM MgCl2, 1 mM DTE, 50 μM DTPA, 0.1 mg/mL BSA, 25 μM D-luciferin, 2 μg luciferase, 20 mU PPase, 25 ng guanylyl cyclase, 10 mU sulfurylase, 50 U superoxide dismutase, 10 μM APS and 0.1 mM GTP in HEPES-based buffer.
2.3.2. NO measurements
Stock solutions of low molecular weight and protein components were prepared and kept on ice. Low molecular weight components solution contained MgCl2, DTE, luciferin, APS and GTP. Protein components solution contained DTPA, PPase, SOD, luciferase and BSA. Concentrations of the components were chosen in such a way that addition of small aliquots gave the final concentrations shown above. Before the measurements, cells were rinsed twice and the medium was replaced with warm HEPES-based medium. Low molecular weight (6.2 μL) and protein (8.0 μL) components of the assay mixture were added to the wells and left for temperature stabilization and residual pyrophosphate hydrolysis (2 min). Then, sulfurylase was added and luminescence without sGC was recorded. Next, 2 μL of sGC were added and the luminescence kinetics was recorded for 3 min. For endothelial cells, stimulus (bradykinin or Ca2+ ionophore) was added after sulfurylase, followed by 90 s delay and addition of sGC + EGTA; then, luminescence kinetics was recorded. In all the experiments luminescence integration time was 1 s.
2.3.3. Shaking
Shaking was done directly in the Victor3 luminometer prior to reading with the following parameters: double orbital path, diameter 0.2 mm, slow speed (10 mm/s), duration 5 s.
2.3.4. Nitrite measurements
Cells were rinsed twice with MP-HEPES medium and incubated for a specified time at 37 °C. Then, 150 μL of the media was taken to separate plate for nitrite analysis, which proceeded by adding 1.5 μL of 1 mM diaminonaphthalene and 0.63 μL of 12.1 M HCl to each well. Samples were incubated for 30 min in the dark and then 3.3 μL of 3 M NaOH was added. Sodium nitrite in the same buffer was used as a standard. Nitrite was determined by fluorescence with excitation at 365 nm and emission at 404 nm.
2.4. Calculations
The primary data are the kinetics of luminescence change. The rate of the luminescence change, calculated as a slope of the kinetics, depends on the NO generation rate and can be used for NO quantitation in the sample. As luminescence intensity is measured in counts per second (cps), the rate of luminescence change would be measured in “counts per second per second” (cps2). The method was calibrated with known concentrations of the NO donor, DETA NONOate, using the protocol described above in NO measurements. DETA NONOate was added to the assay mixture in the wells without cells or with non – NO generating cells (quiescent macrophages). Typical calibration (Fig. 1, Supplement) shows the dependence of the luminescence increase rate on concentration of NO donor to be approximately linear at low concentrations of the donor. The rate of NO generation was determined from the change of DETA-NONOate absorbance at 252 nm. It was 0.80 nM/min of NO per 1 μM of donor concentration under the conditions of cellular assays. This value is close to the one reported in literature [20]. The calibration curve was produced for every series of experiments.
Fig. 1.

NO generation by RAW 264.7 cells measured by luciferase chemiluminescence. Cells were stimulated by INF-γ and LPS. The medium was replaced with 200 μL of MP-HEPES prior to measurement. Two types of controls were used: reaction containing all the components except sGC and reaction containing unstimulated cells. A, individual kinetics, 1.0 × 103 cells per well. B, NO production, depending on the number of cells. C, Nitrite production by RAW cells (2.5 × 104 per well), fluorometric measurements; “media” means buffer without cells. D, Inhibition of NO production by L-NAME, added to the stimulated cells (1.0 × 104 per well) in standard growth medium 50 min prior to measurements. E, Inhibition of NO production by 7-nitroindazole (50 μM) added directly before measurement; 2.0 × 103 cells/well. Average of duplicates (B, C, E) or triplicate (D). **P < 0.05, ***P < 0.005, vs. no inhibitor.
2.5. Statistical analysis
All values presented in this paper are expressed as the mean ± standard error of the mean; the same are error bars on the graphs. One-way Student t test was used to calculate statistical significance.
3. Results
3.1. Choice of luciferase for the cellular assay
Initial experiments were conducted with wild-type firefly luciferase. However, its instability at 37 °C made quantitative measurements difficult. Two thermostable engineered luciferases: Ultra-Glo (Promega) and GR-TS [19] were tested along with wild type firefly luciferase. As GR-TS luciferase showed the least variation of luminescence over time, it was chosen for further experiments (see Supplement for details).
3.2. Choice of the buffer
Phosphate-containing buffers cannot be used in our assay, as phosphate interferes with pyrophosphate detection. Therefore, HEPES buffers of physiological osmolarity were used. To test cell tolerance, the cells were rinsed and incubated in the buffer for 10 min (the time required for the measurement), then medium was replaced with standard growth medium and the cells were examined under the microscope. We found neither morphological changes nor changes in the number of cells after such treatment.
3.3. Detection of nitric oxide in cellular systems
The method was applied to measurement of NO production by RAW 264.7 cells, bone marrow-derived murine macrophages and BAEC. The primary kinetics traces shown in Fig. 1A correspond to 1.0×103 RAW cells in a 96-well plate. The cell number-dependent NO generation rate for the same cells (Fig. 1B) was calculated using calibration with NO donor DETA NONOate; the rate of NO production was (96 ± 11) amol/(min·cell). To confirm this quantitation, we measured the final product of NO oxidation, nitrite, with the same cells (Fig. 1C). Due to lower sensitivity, these measurements require a higher number of cells and longer time for nitrite accumulation. However, the calculated nitrite production rate, (78 ± 8) amol/(min·cell) was in agreement with the number calculated from NO measurements.
To confirm the specificity of the observed luminescence increase, the cells were treated with inhibitors of NO-synthase, L-NAME and 7-nitroindazole (Fig. 1D, E). Another inhibitor of NO-synthase, L-NMMA, produces similar results (Supplement Fig. 3).
Analogous results were obtained with primary murine bone marrow-derived macrophages. Rates of NO generation, 80–140 amol/(min·cell) were recorded for cells stimulated by the scheme described in Materials and methods, while quiescent cells exhibit negligible NO production, 0–0.2 amol/(min·cell).
The other cellular system, BAEC, requires Ca2+ in the buffer, and this ion inhibits sGC [21]. To overcome the problem, cells were incubated with all the components of the assay, then Ca2+ chelator (EGTA) along with sGC were added and luminescence kinetics was recorded. The presence of 1 mM Ca2+ does not affect the luminescence without sGC and chelated Ca2+ does not affect the activity of sGC [21]. When the effect of bradykinin or Ca2+ ionophore (A23187) on NO production was examined, the 90 s delay was introduced before adding sGC + EGTA. The results of the experiments are shown in Fig. 2. In these experiments the luminescence increase for both stimulated (A23187 or bradykinin) and non-stimulated cells is fully attributed to NO generation, as is proven by negligible slope of the kinetics without sGC (Fig. 2A, dotted line) and by inhibition with L-NAME (Fig. 2B, C). Endothelial cells sensitivity to mechanical stimulation is a cornerstone of vascular physiology, so it would be important to observe this sensitivity using chemiluminescent method. Special equipment is required to produce quantitatively defined shear stress; however, ordinary shaking necessarily involves shear stress and can be used for qualitative observations. Indeed, the cells responded to shaking in a manner dependent on cell number and the response was abolished by adding an eNOS inhibitor or by omitting sGC (Fig. 2D). The negative value for the control in the absence of sGC reflects a slightly negative slope of the kinetic curve explained by a slow decay of luciferase-dependent luminescence (Supplement Fig. 2). The data show that, unlike quiescent macrophages, endothelial cells maintain a basal level of NO production, which increases in response to different stimuli and is strongly inhibited by L-NAME, a specific eNOS inhibitor. Based on calibration with NO donor, the rate of NO production was 4.8 ± 1.8 amol/(cell·min) for basal and 7.4 ± 1.8, 11 ± 2.5 and 9.4 ± 0.5 amol/(cell·min) for A23187, bradykinin and mechanically-stimulated cells, respectively.
Fig. 2.

NO generation by BAEC measured by luciferase chemiluminesce. After addition of the components of the assay and temperature stabilization, Ca2+ ionophore A23187 (1 μM) or bradykinin (10 μM), was added. Then, after 90 s delay, Ca2+ chelator (EGTA) and sGC were added and kinetic was recorded. For background measurement, sGC was omitted; for basal NO generation, buffer was added instead of stimulant. A, primary kinetic curves for background (−sGC), basal (+sGC) and Ca2+- stimulated (+sGC + A23178) NO generation. B, rate of NO generation for bradykinin- or A23187-stimulated, basal and L-NAME-inhibited luminescence. L-NAME (1 mM) was added to growth medium 1 h prior to the measurements. Average of triplicates. C, effect of L- and D-NAME, added 15 min prior to measurements, on NO generation. D, NO generation induced by mechanical stress (shaking). Cells were shaken directly in the plate reader immediately after addition of sGC. Shaking parameters are given in Materials and methods. Measurements were conducted in Hi HEPES medium without Ca2+. Bars represent 1.0 × 103 and 3.0 × 103 cells with full NO detection system, 3.0 × 103 cells preincubated with L-NAME for 1 h, 3.0 × 103 cells with NO detection system missing sGC and 3.0 × 103 cells with full NO detection system without shaking. The last one is recalculated from the measurements made with 3.0 × 104 cells. **P < 0.05 vs. basal level, ***P < 0.005 vs. non-shaking.
3.4. Comparison of sensitivity of chemiluminescent and fluorescent detection of NO
Fig. 3 shows the results of the experiment where either RAW cells (1.0×104 cells per well) or synthetic NO donor were used as a source of nitric oxide, with detection by either 10 μM DAF-FM (Fig. 3A, B) or by the chemiluminescent assay (Fig. 3C, D). As can be seen, barely visible increase in fluorescence was observed with 5 μM of DETA NONOate after 120 min, while chemiluminescent detection generates an excellent kinetic curve with 1.25 μM of NO donor in 100 s or less. For either source of NO, the chemiluminescent method appears to be two orders of magnitude more sensitive.
Fig. 3.

Comparison of sensitivity for fluorescent NO indicator DAF-FM and sGC-luciferase chemiluminescence. Measurements were conducted in Hi HEPES using 96-well plates, with DETA NONOate or RAW cells as a source of NO. A, Different concentrations of DETA NONOate were added to the buffer containing DAF-FM (10 μM) and incubated at 37 °C in the dark for specified time. B, DAF-FM (10 μM) was added to 1.0 × 104 RAW 264.7 cells stimulated as described or unstimulated. At a specified time, 150 μL was withdrawn and fluorescence was measured with 485 nm excitation and 535 nm emission filters. C, DETA NONOate was added to the buffer containing all the components of sGC-luciferase assay. D, all the components of sGC-luciferase assay were added to the same cells as in B. Notice the different time scale on the panels.
4. Discussion
4.1. Background luminescence
The suggested method is based on the activation of sGC by nitric oxide. It leads to exceptional sensitivity, as one molecule of sGC, being activated by one molecule of NO, can produce many molecules of pyrophosphate, which is detected after conversion to ATP. Obviously, lower background is desirable for the improved sensitivity: to this end, cells were treated with pyrophosphatase before the measurements. However, as the concentration of NO translates to the rate of ATP production with proportional rate of the luminescence increase, the level of the background luminescence is not critically important, giving an additional advantage to the method.
4.2. Sensitivity and limitations
To achieve maximal sensitivity, most of NO should be bound to sGC, meaning concentration of the enzyme to be higher than KD and NO concentration. However, these conditions could be impractical due to high cost of purified guanylyl cyclase. As seen from Fig. 2D, 0.8 nM concentration of sGC used in our assays allows for the measurement of NO generation rates as low as 50 pM/min. This corresponds to detection of NO generated by 102–103 cells like murine macrophages or (1–5) × 103 cells of endothelial lineage. The method is more applicable for relatively low NO generation rates in order to avoid saturation of sGC (Fig. 1, Supplement). The other limitation is the involvement of ATP and PPi in the detection, so method cannot be applied to ATP-effusing cells, neither can it be used to study the effect of extracellular ATP on cell physiology. However, physiological effects, including change in NO production, were observed at extracellular ATP concentrations of 10–300 μM [22–25], while maximal concentration of ATP generated in our experiments did not exceed 100 nM, even for the most intensely NO-generating cells. That means the detection method does not directly interfere with cell physiology.
4.3. Basal generation of NO by BAEC; no generation by quiescent macrophages
The presented data show that basal NO generation by endothelial cells is substantial and increases about 2–3 times upon stimulation. This corresponds to the role of eNOS, maintaining vascular tone, which has to rapidlychange in response to physiological stimuli (shear stress, bradykinin). The fact that the basal and stimulated activities are both eNOS-mediated is supported by the strong inhibition by the specific eNOS inhibitor, L-NAME. For macrophages the expression of iNOS is triggered by external stimuli (bacterial LPS, cytokines) and in quiescent cells, NO-generating activity is undetectable.
4.4. Numerical comparison with data produced by other methods
Quantitative data concerning NO production by different cell types are scarce. The data for stimulated murine macrophages (ANA-1 cell line) demonstrate the rates of about 100 amol/(cell·min) [26], in agreement with our quantitation. Other work reports a yield of 7 amol/(cell·min) [27]; the difference may be explained by dissimilarity in cell lines (J774) and stimulation scheme. NO production by macrophages can be compared with the total oxygen consumption by the same type of cells, which is about 500 amol/(cell·min) [28]. Evidently, the substantial part of consumed oxygen (about 40%) in these cells is spent on NO production. For endothelial cells, studies report the values from 0.6 to 3 amol/(cell·min) and bradykinin-stimulated increase of 3–6 times over the basal rate [23,29,30]. Our results agree with those data produced by different methods.
4.5. Shear stress quantitation
Calculation of shear stress originating from orbital shaking of cell cultures is widely discussed in literature [31–33]. The reason for this is universal accessibility of orbital shakers, while the devices specifically intended for providing defined shear stress are still uncommon. The calculations performed for standard 6-well culture plate [32] showed great non-uniformity of shear stress both over the orbiting cycle and across the well. However, the average shear stress magnitude over the bottom of the well falls fairly close to the value predicted by analytical solution for the simpler model of infinite plate orbiting beneath a liquid layer of large height:
| (1) |
where τ is shear stress, Rg is orbiting radius, Ω is angular orbital speed, ρ is density and μ is dynamic viscosity.
The average shear stress value of 0.1 Pa was calculated using Equation (1) for our settings. Shear stress of this magnitude, though lower than in physiological conditions for human arteries (0.5 Pa, [34]), caused visible elevation in NO production measured by NO electrode [29]. It should be noted, that the value of 0.1 Pa presents an estimate of the average shear stress; the peak values could be an order of magnitude higher.
In summary, the chemiluminescent method for extracellular measurement of NO production was successfully applied to different cell types. The method allows to measure NO generated by 102–104 cells. The method is fast (2–3 min per measurement), does not require pre-loading cells with dye, and well-suited for high-throughput screening. Appropriate instrumentation (CCD-based luminometer with automatic injectors) will allow kinetics in all wells to be recorded simultaneously providing information for drug screening and other applications.
Supplementary Material
Acknowledgments
YYW acknowledges the support of Valdosta State University Faculty Research Seed Grants (Fiscal Year 2011–12 and 2013–14) and thanks Dr. Jesse Spencer (Valdosta State University) for help with manuscript preparation. BRB acknowledges the financial support of the National Science Foundation (MCB1410390) and the Air Force Office of Scientific Research (FA9550-14-1-0100).
Abbreviations
- APS
adenosine-5′-phosphosulfate
- BAEC
bovine aortic endothelial cells
- BSA
bovine serum albumin
- cGMP
guanosine 3′,5′-cyclic mono-phosphate
- cps
counts per second
- cps2
counts per second per second
- DETA NONOate
diethylenetriamine NONOate
- DMEM
Dulbecco’s modified Eagle’s medium
- DTE
1,4-dithioerythritol
- DTPA
diethylenetriamine-pentaacetic acid
- DTT
dithiothreitol
- EGTA
ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid
- eNOS
endothelial nitric oxide synthase
- FBS
fetal bovine serum
- INF-γ
murine interferon γ
- iNOS
inducible nitric oxide synthase
- LPS
E. coli lipopolysaccharide
- M-CSF
macrophage colony-stimulating factor
- L(D)-NAME
NG-nitro-L(D)-arginine methyl ester
- NMMA
NG-monomethyl- L-arginine
- PPi
inorganic pyro-phosphate
- PPase
inorganic pyrophosphatase
- sGC
soluble guanylyl cyclase
- SOD
superoxide dismutase
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.bbrc.2015.08.001.
Footnotes
Transparency document
Transparency document related to this article can be found online at http://dx.doi.org/10.1016/j.bbrc.2015.08.001.
References
- 1.Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265–9269. doi: 10.1073/pnas.84.24.9265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988;336:385–388. doi: 10.1038/336385a0. [DOI] [PubMed] [Google Scholar]
- 3.Tripathi P. Nitric oxide and immune response. Indian J Biochem Biophys. 2007;44:310–319. [PubMed] [Google Scholar]
- 4.MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323–350. doi: 10.1146/annurev.immunol.15.1.323. [DOI] [PubMed] [Google Scholar]
- 5.Bukrinsky MI, Nottet HS, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med. 1995;181:735–745. doi: 10.1084/jem.181.2.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO, 3rd, Schechter AN, Gladwin MT. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383–1389. doi: 10.1038/nm1202-799. [DOI] [PubMed] [Google Scholar]
- 7.Hartell NA, Archer HE, Bailey CJ. Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B. Biochem Pharmacol. 2005;69:781–790. doi: 10.1016/j.bcp.2004.11.022. [DOI] [PubMed] [Google Scholar]
- 8.Hoffmeyer F, Raulf-Heimsoth M, Merget R, Bruning T. EBC: a new matrix for assessment of airway and lung inflammation. Current aspects of environmental and occupational medicine. Pneumologie. 2009;63:426–432. doi: 10.1055/s-0029-1214981. [DOI] [PubMed] [Google Scholar]
- 9.van Eijk HM, Luiking YC, Deutz NE. Methods using stable isotopes to measure nitric oxide (NO) synthesis in the L-arginine/NO pathway in health and disease. J Chromatogr B Anal Technol Biomed Life Sci. 2007;851:172–185. doi: 10.1016/j.jchromb.2006.08.054. [DOI] [PubMed] [Google Scholar]
- 10.Morris CR, Gladwin MT, Kato GJ. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr Mol Med. 2008;8:620–632. doi: 10.2174/156652408786241447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006;6:521–534. doi: 10.1038/nrc1910. [DOI] [PubMed] [Google Scholar]
- 12.Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med. 1995;1:804–809. doi: 10.1038/nm0895-804. [DOI] [PubMed] [Google Scholar]
- 13.Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med. 2007;43:645–657. doi: 10.1016/j.freeradbiomed.2007.04.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hong H, Sun J, Cai W. Multimodality imaging of nitric oxide and nitric oxide synthases. Free Radic Biol Med. 2009;47:684–698. doi: 10.1016/j.freeradbiomed.2009.06.011. [DOI] [PubMed] [Google Scholar]
- 15.Marques SM, Esteves da Silva JCG. A nitric oxide quantitative assay by a glyceraldehyde 3-phosphate dehydrogenase/phosphoglycerate kinase/firefly luciferase optimized coupled bioluminescent assay. Anal Methods. 2014;6:3741–3750. [Google Scholar]
- 16.Sano Y, Seki M, Abe S, Suzuki S, Arakawa H. Bioluminescent assay for nitric oxide utilizing the biological enzyme activity of soluble guanylate cyclase. Anal Lett. 2011;44:2834–2840. [Google Scholar]
- 17.Woldman YY, Sun J, Zweier JL, Khramtsov VV. Direct chemiluminescence detection of nitric oxide in aqueous solutions using the natural nitric oxide target soluble guanylyl cyclase. Free Radic Biol Med. 2009;47:1339–1345. doi: 10.1016/j.freeradbiomed.2009.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kimura C, Oike M, Koyama T, Ito Y. Impairment of endothelial nitric oxide production by acute glucose overload. Am J Physiol Endocrinol Metab. 2001;280:E171–E178. doi: 10.1152/ajpendo.2001.280.1.E171. [DOI] [PubMed] [Google Scholar]
- 19.Branchini BR, Ablamsky DM, Murtiashaw MH, Uzasci L, Fraga H, Southworth TL. Thermostable red and green light-producing firefly luciferase mutants for bioluminescent reporter applications. Anal Biochem. 2007;361:253–262. doi: 10.1016/j.ab.2006.10.043. [DOI] [PubMed] [Google Scholar]
- 20.Keefer LK, Nims RW, Davies KM, Wink DA. “NONOates”(1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 1996;268:281–293. doi: 10.1016/s0076-6879(96)68030-6. [DOI] [PubMed] [Google Scholar]
- 21.Serfass L, Carr HS, Aschenbrenner LM, Burstyn JN. Calcium ion down-regulates soluble guanylyl cyclase activity: evidence for a two-metal ion catalytic mechanism. Arch Biochem Biophys. 2001;387:47–56. doi: 10.1006/abbi.2000.2090. [DOI] [PubMed] [Google Scholar]
- 22.D’Amico Oblak T, Root P, Spence DM. Fluorescence monitoring of ATP-stimulated, endothelium-derived nitric oxide production in channels of a poly(dimethylsiloxane)-based microfluidic device. Anal Chem. 2006;78:3193–3197. doi: 10.1021/ac052066o. [DOI] [PubMed] [Google Scholar]
- 23.Kotsis DH, Spence DM. Detection of ATP-induced nitric oxide in a biomimetic circulatory vessel containing an immobilized endothelium. Anal Chem. 2003;75:145–151. doi: 10.1021/ac0258249. [DOI] [PubMed] [Google Scholar]
- 24.Murakami K, Nakamura Y, Yoneda Y. Potentiation by ATP of lipopolysaccharide-stimulated nitric oxideproductionin cultured astrocytes. Neuroscience. 2003;117:37–42. doi: 10.1016/s0306-4522(02)00804-7. [DOI] [PubMed] [Google Scholar]
- 25.Sperlagh B, Hasko G, Nemeth Z, Vizi ES. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2×7 receptors. Neurochem Int. 1998;33:209–215. doi: 10.1016/s0197-0186(98)00025-4. [DOI] [PubMed] [Google Scholar]
- 26.Espey MG, Miranda KM, Pluta RM, Wink DA. Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals. J Biol Chem. 2000;275:11341–11347. doi: 10.1074/jbc.275.15.11341. [DOI] [PubMed] [Google Scholar]
- 27.Tiscornia A, Cairoli E, Marquez M, Denicola A, Pritsch O, Cayota A. Use of diaminofluoresceins to detect and measure nitric oxide in low level generating human immune cells. J Immunol Methods. 2009;342:49–57. doi: 10.1016/j.jim.2008.11.014. [DOI] [PubMed] [Google Scholar]
- 28.Wagner BA, Venkataraman S, Buettner GR. The rate of oxygen utilization by cells. Free Radic Biol Med. 2011;51:700–712. doi: 10.1016/j.freeradbiomed.2011.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Andrews AM, Jaron D, Buerk DG, Kirby PL, Barbee KA. Direct, real-time measurement of shear stress-induced nitric oxide produced from endothelial cells in vitro. Nitric Oxid. 2010;23:335–342. doi: 10.1016/j.niox.2010.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Harris MB, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, Chen ZP, Kemp BE, Venema RC. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem. 2001;276:16587–16591. doi: 10.1074/jbc.M100229200. [DOI] [PubMed] [Google Scholar]
- 31.Dardik A, Chen L, Frattini J, Asada H, Aziz F, Kudo FA, Sumpio BE. Differential effects of orbital and laminar shear stress on endothelial cells. J Vasc Surg. 2005;41:869–880. doi: 10.1016/j.jvs.2005.01.020. [DOI] [PubMed] [Google Scholar]
- 32.Salek MM, Sattari P, Martinuzzi RJ. Analysis of fluid flow and wall shear stress patterns inside partially filled agitated culture well plates. Ann Biomed Eng. 2012;40:707–728. doi: 10.1007/s10439-011-0444-9. [DOI] [PubMed] [Google Scholar]
- 33.Berson RE, Purcell MR, Sharp MK. Computationally determined shear on cells grown in orbiting culture dishes. Adv Exp Med Biol. 2008;614:189–198. doi: 10.1007/978-0-387-74911-2_22. [DOI] [PubMed] [Google Scholar]
- 34.Greve JM, Les AS, Tang BT, Draney Blomme MT, Wilson NM, Dalman RL, Pelc NJ, Taylor CA. Allometric scaling of wall shear stress from mice to humans: quantification using cine phase-contrast MRI and computational fluid dynamics. Am J Physiol Heart Circ Physiol. 2006;291:H1700–H1708. doi: 10.1152/ajpheart.00274.2006. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
